HTR2A and Parkinson disease: In addition, a study supported a possible contribution of genetic variation in the HTR2A (serotonin 2A receptor gene) to the susceptibility of ICDs in PD patients, with the T allele, which is presumably linked to higher receptor expression, increasing the risk by 2.8 and 6.9 times in CT and TT carriers (61).